Free Trial

TD Asset Management Inc. Decreases Holdings in Danaher Co. (NYSE:DHR)

Danaher logo with Medical background
Remove Ads

TD Asset Management Inc. lessened its stake in Danaher Co. (NYSE:DHR - Free Report) by 13.8% in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 1,545,548 shares of the conglomerate's stock after selling 248,087 shares during the quarter. TD Asset Management Inc. owned approximately 0.21% of Danaher worth $354,781,000 at the end of the most recent reporting period.

A number of other large investors also recently added to or reduced their stakes in DHR. Kentucky Retirement Systems Insurance Trust Fund raised its position in shares of Danaher by 11.6% during the 4th quarter. Kentucky Retirement Systems Insurance Trust Fund now owns 21,233 shares of the conglomerate's stock worth $4,874,000 after purchasing an additional 2,202 shares during the last quarter. ORG Partners LLC raised its holdings in shares of Danaher by 1,212.8% during the fourth quarter. ORG Partners LLC now owns 2,770 shares of the conglomerate's stock valued at $636,000 after acquiring an additional 2,559 shares during the last quarter. Generate Investment Management Ltd purchased a new position in shares of Danaher in the fourth quarter valued at approximately $8,044,000. Stifel Financial Corp boosted its stake in shares of Danaher by 1.3% in the third quarter. Stifel Financial Corp now owns 847,348 shares of the conglomerate's stock worth $235,583,000 after acquiring an additional 11,216 shares during the last quarter. Finally, Compass Capital Management Inc. increased its position in shares of Danaher by 4.8% during the fourth quarter. Compass Capital Management Inc. now owns 237,922 shares of the conglomerate's stock worth $54,615,000 after purchasing an additional 10,994 shares in the last quarter. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Remove Ads

Insider Activity at Danaher

In related news, SVP Brian W. Ellis sold 5,700 shares of the firm's stock in a transaction that occurred on Thursday, January 30th. The shares were sold at an average price of $224.13, for a total value of $1,277,541.00. Following the sale, the senior vice president now owns 20,230 shares of the company's stock, valued at $4,534,149.90. This trade represents a 21.98 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 11.10% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

Several equities research analysts have issued reports on DHR shares. Raymond James reaffirmed a "market perform" rating on shares of Danaher in a research note on Monday, February 3rd. Wells Fargo & Company dropped their price objective on shares of Danaher from $280.00 to $240.00 and set an "equal weight" rating for the company in a research note on Thursday, January 30th. Citigroup decreased their target price on shares of Danaher from $285.00 to $265.00 and set a "buy" rating on the stock in a research note on Thursday, January 30th. JPMorgan Chase & Co. cut their price target on Danaher from $310.00 to $300.00 and set an "overweight" rating for the company in a report on Tuesday, January 28th. Finally, Barclays lowered their price objective on Danaher from $275.00 to $240.00 and set an "equal weight" rating on the stock in a research note on Thursday, January 30th. Five equities research analysts have rated the stock with a hold rating and seventeen have given a buy rating to the company's stock. Based on data from MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus target price of $278.24.

Check Out Our Latest Stock Analysis on Danaher

Danaher Trading Down 1.8 %

Danaher stock traded down $3.75 during midday trading on Friday, reaching $206.04. 1,030,975 shares of the stock traded hands, compared to its average volume of 4,350,791. The firm has a market cap of $147.26 billion, a PE ratio of 39.00, a price-to-earnings-growth ratio of 2.66 and a beta of 0.82. The company has a current ratio of 1.40, a quick ratio of 1.05 and a debt-to-equity ratio of 0.31. The company has a 50-day simple moving average of $215.23 and a two-hundred day simple moving average of $237.37. Danaher Co. has a 12-month low of $196.80 and a 12-month high of $281.70.

Danaher (NYSE:DHR - Get Free Report) last posted its quarterly earnings data on Wednesday, January 29th. The conglomerate reported $2.14 EPS for the quarter, meeting the consensus estimate of $2.14. Danaher had a net margin of 16.33% and a return on equity of 10.82%. During the same period last year, the business earned $2.09 earnings per share. Research analysts expect that Danaher Co. will post 7.63 earnings per share for the current fiscal year.

Danaher Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Stockholders of record on Friday, March 28th will be given a dividend of $0.32 per share. The ex-dividend date of this dividend is Friday, March 28th. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.62%. This is a positive change from Danaher's previous quarterly dividend of $0.27. Danaher's dividend payout ratio is currently 24.24%.

Danaher Company Profile

(Free Report)

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

Read More

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Should You Invest $1,000 in Danaher Right Now?

Before you consider Danaher, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Danaher wasn't on the list.

While Danaher currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

Time to Buy SoFi? Fintech’s Next Big Move
3 Chip Stocks Primed for a Comeback—Have They Found the Bottom?
Why Palantir’s Future Just Got a Massive Boost

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads